Retraction
LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis
Paper Information
Record ID:
40594
Publication Date:
December 01, 2019
Retraction Date:
December 01, 2022
(3.0 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Verduci Editore
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.26355/eurrev_202205_28719Citations (17)
17
Total Citations0
Post-Retraction17
Pre-Retraction0
Same DayMutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer
Liansha Tang, Wanjiang Li, Hang Xu et al. (10 authors)
Frontiers in Oncology
Open Access
Published: Jul 2022
2 citations
2 citations
150 days before retraction
The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches
Ana Paula Alarcón-Zendejas, Anna Scavuzzo, Miguel Ángel Jiménez-Ríos et al. (12 authors)
Prostate Cancer and Prostatic Diseases
Open Access
Published: Apr 2022
67 citations
67 citations
231 days before retraction
The lncRNA NEAT1/miRNA-766-5p/E2F3 Regulatory Axis Promotes Prostate Cancer Progression
Wenhui Zhao, Xinshu Zhu, Jin Qiu et al. (5 authors)
Journal of Oncology
Open Access
Published: Feb 2022
21 citations
21 citations
283 days before retraction
lncRNA TUG1 Facilitates Colorectal Cancer Stem Cell Characteristics and Chemoresistance by Enhancing GATA6 Protein Stability
Junfeng Sun, Hangyuan Zhou, Xingqi Bao et al. (7 authors)
Stem Cells International
Open Access
Published: Nov 2021
19 citations
19 citations
373 days before retraction
Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis
Xiulin Jiang, Yixiao Yuan, Lin Tang et al. (7 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Nov 2021
38 citations
38 citations
386 days before retraction
Non-coding Natural Antisense Transcripts: Analysis and Application
Julian Krappinger, Lilli Bonstingl, Katrin Pansy et al. (12 authors)
Journal of Biotechnology
Published: Aug 2021
21 citations
21 citations
480 days before retraction
GANLDA: Graph attention network for lncRNA-disease associations prediction
Wei Lan, WU Xi-min, Qingfeng Chen et al. (6 authors)
Neurocomputing
Published: Jul 2021
78 citations
78 citations
497 days before retraction
Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway
Rui Zhang, Fan Yang, Haitao Fan et al. (7 authors)
Cell Death and Disease
Open Access
Published: May 2021
27 citations
27 citations
559 days before retraction
LncRNA Taurine Upregulated Gene 1 as a Potential Biomarker in the Clinicopathology and Prognosis of Multiple Malignant Tumors: A Meta-Analysis
Qi Huang, Jingjing Wu, Hui Wang et al. (6 authors)
Disease Markers
Open Access
Published: Mar 2021
3 citations
3 citations
639 days before retraction
Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review)
Stella Baliou, A. Kyriakopoulos, Demetrios�� Spandidos et al. (4 authors)
International Journal of Oncology
Open Access
Published: Jul 2020
39 citations
39 citations
870 days before retraction
Over-expression of long non-coding RNA ZEB2-AS1 may predict poor prognosis and promote the migration, invasion, and epithelial-mesenchymal transition of tumor cells in non-small cell lung cancer
Hui Xu, Bengtong Yu, Weiyu Shen et al. (6 authors)
The International Journal of Biological Markers
Open Access
Published: Jul 2020
7 citations
7 citations
882 days before retraction
Identifying Long Non-coding RNA of Prostate Cancer Associated With Radioresponse by Comprehensive Bioinformatics Analysis
Meng Xu, Shiqi Gong, Yue Li et al. (10 authors)
Frontiers in Oncology
Open Access
Published: Apr 2020
9 citations
9 citations
968 days before retraction
<p>Knockdown of lncRNA TUG1 Enhances Radiosensitivity of Prostate Cancer via the TUG1/miR-139-5p/SMC1A Axis</p>
Dianhui Xiu, Lin Liu, Min Cheng et al. (5 authors)
OncoTargets and Therapy
Open Access
Published: Mar 2020
48 citations
48 citations
1005 days before retraction
lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET
Pan Wang, Zhuanbo Yang, Ting Ye et al. (7 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Jan 2020
52 citations
52 citations
1057 days before retraction
Long non-coding RNA TUG1 promotes cell progression in hepatocellular carcinoma via regulating miR-216b-5p/DLX2 axis
Qun Dai, Jingyi Deng, Jin‐Rong Zhou et al. (7 authors)
Cancer Cell International
Open Access
Published: Jan 2020
38 citations
38 citations
1059 days before retraction
Inhibition of long non-coding RNA TUG1 protects against diabetic cardiomyopathy induced diastolic dysfunction by regulating miR-499-5p.
Lei Zhao, Weiguo Li, Hao Zhao
PubMed
Published: Jan 2020
25 citations
25 citations
1065 days before retraction
LncRNA TUG1 Targets miR-222-3p to Take Part in Proliferation and Invasion of Breast Cancer Cells
Yuqin Xie, Shuang Deng, Qian Deng et al. (4 authors)
ONCOLOGIE
Open Access
Published: Jan 2020
1065 days before retraction
Quick Stats
Total Citations:
17
Years Since Retraction:
3.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025